Refinement was completed after several rounds of model correction, thereby imposing non-crystallographic restraints on residues 15:50, 54:81, 100:106, 135:220, 227:240, 279:335, 342:410, 412:428, and 434:490
This accumulated data provides substantive support for the peptides ability to improve skin quality and address laxity
PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan flat, regardless of your dose level, making it affordable to progress through the titration schedule as your provider determines your individual needs
The above describes how this compound is characterised in the published peer-reviewed literature